Hamilton Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hamilton Wealth's BMY Position: Q2 2026 in Review
Hamilton Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 87,412 shares — an estimated $5.3M sold.
Hamilton Wealth first reported a position in BMY in Q2 2019 and held it in 19 quarters. The position peaked at $10.1M in Q3 2024. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hamilton Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Hamilton Wealth sold 87,412 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.3M.
- Hamilton Wealth first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 19 quarters.
- Hamilton Wealth's Bristol-Myers Squibb position peaked at $10.1M in Q3 2024.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.